Publications

Found 5 results
Filters: Author is Revets, Hilde  [Clear All Filters]
2007
Roovers, R. C., T. Laeremans, L. Huang, S. De Taeye, A. J. Verkleij, H. Revets, H. J. de Haard, and P. M. P. van Be Henegouwen, "Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.", Cancer Immunol Immunother, vol. 56, issue 3, pp. 303-317, 2007 Mar.
2005
Revets, H., P. De Baetselier, and S. Muyldermans, "Nanobodies as novel agents for cancer therapy.", Expert Opin Biol Ther, vol. 5, issue 1, pp. 111-24, 2005 Jan.
2004
Cortez-Retamozo, V., N. Backmann, P. D. Senter, U. Wernery, P. De Baetselier, S. Muyldermans, and H. Revets, "Efficient cancer therapy with a nanobody-based conjugate.", Cancer Res, vol. 64, issue 8, pp. 2853-7, 2004 Apr 15.
Stijlemans, B., K. Conrath, V. Cortez-Retamozo, H. Van Xong, L. Wyns, P. Senter, H. Revets, P. De Baetselier, S. Muyldermans, and S. Magez, "Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm.", J Biol Chem, vol. 279, issue 2, pp. 1256-61, 2004 Jan 9.
2002
Cortez-Retamozo, V., M. Lauwereys, G. Hassanzade Gh, M. Gobert, K. Conrath, S. Muyldermans, P. De Baetselier, and H. Revets, "Efficient tumor targeting by single-domain antibody fragments of camels.", Int J Cancer, vol. 98, issue 3, pp. 456-62, 2002 Mar 20.